Literature DB >> 30075170

The association of excitation and inhibition signaling with the relative symptom expression of autism and psychosis-proneness: Implications for psychopharmacology.

Talitha C Ford1, Ahmad Abu-Akel2, David P Crewther3.   

Abstract

The underlying mechanisms of autism and schizophrenia are poorly understood, partly due to a lack of dimension-specific research. Aberrant excitatory and inhibitory neurotransmission are implicated in both conditions, particularly in social dysfunction. This study investigates the extent to which the degree of autistic tendency and psychosis-proneness exclusively and interactively predict excitatory and inhibitory neurotransmitter concentrations in the superior temporal cortex (STC). In 38 adults (18 male, 18-40 years), we obtained autistic tendencies (Autism-Spectrum Quotient [AQ]) and psychosis-proneness scores (Schizotypal Personality Questionnaire [PP]); magnetic resonance spectroscopy (MRS) quantified glutamate and GABA+ concentrations from the STC. Results demonstrated a negative AQ/PP interaction with glutamate concentration for the left STC voxel, where PP increased with glutamate for average AQ, while AQ decreased with glutamate for average-high PP. There was a negative AQ/PP interaction with glutamate/GABA+ ratio for the right STC, AQ increasing with glutamate/GABA+ for low-average PP, while PP decreased with glutamate/GABA+ for high AQ. Consistent with animal studies, we also reveal that overall reduced glutamate/GABA+ ratio might be precipitated by increased right hemisphere GABA+ concentrations. These findings illustrate the importance of considering the concurrent effects of autism and psychosis dimensions on understanding the pathophysiological mechanisms implicated in either condition, and can advance psychopharmacological research into better treatment options for patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; GABA; Glutamate; MRS; Psychosis-proneness

Mesh:

Substances:

Year:  2018        PMID: 30075170     DOI: 10.1016/j.pnpbp.2018.07.024

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  Psychosocial functioning in the balance between autism and psychosis: evidence from three populations.

Authors:  Ahmad Abu-Akel; Stephen J Wood; Rachel Upthegrove; Katharine Chisholm; Ashleigh Lin; Peter C Hansen; Steven M Gillespie; Ian A Apperly; Christiane Montag
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 13.437

2.  Reduced intrinsic neural timescales in schizophrenia along posterior parietal and occipital areas.

Authors:  Lavinia Carmen Uscătescu; Sarah Said-Yürekli; Lisa Kronbichler; Renate Stelzig-Schöler; Brandy-Gale Pearce; Luise Antonia Reich; Stefanie Weber; Wolfgang Aichhorn; Martin Kronbichler
Journal:  NPJ Schizophr       Date:  2021-11-22

3.  Preliminary evaluation of a novel nine-biomarker profile for the prediction of autism spectrum disorder.

Authors:  Afaf El-Ansary; Wail M Hassan; Maha Daghestani; Laila Al-Ayadhi; Abir Ben Bacha
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.